Wally Soufi, CEO of NovoPath a leader in Anatomic Pathology Software Solutions, continues his companys multi-year commitment to the Alzheimer's Association and encourages CEOs across the country to join him in finding and supporting the causes about which they feel passionate. <\/p>\n
Princeton, NJ (PRWEB) March 09, 2012 <\/p>\n
In 2011, an estimated 5.4 million Americans of all ages had Alzheimers disease. For those 65 and over, this translates to one in eight people, and for individuals age 85 and over, nearly half had Alzheimers disease. As the proportion of the U.S. population over age 65 continues to increase in the coming years, these ratios will continue to escalate. NovoPaths community-minded focus ensures that key programs, services and the latest research are available to the millions of individuals affected by Alzheimers disease. <\/p>\n
Wally Soufi, CEO of NovoPath stated, As with many people reading this, our family has been personally touched by this devastating, poorly understood disease. In addition to the companys commitment to the Alzheimer's Association, NovoPath supports national cancer research efforts, and celebrates their employees volunteer efforts at soup kitchens and a host of NGOs in their local community. Mr. Soufi encourages CEOs across the country to join him in finding and supporting the causes about which they feel passionate. He added, We each have an obligation, and NovoPath looks forward to fulfilling that commitment by continuing in its support of the Alzheimers Association. <\/p>\n
About NovoPathTM, Inc.: <\/p>\n
NovoPath, Inc.TM develops and markets software solutions for the Anatomic Pathology Laboratory market segment that includes local, regional, national, in-house laboratories as well as community and university teaching hospitals and medical centers. Since the release of its flagship product in 1999, NovoPath, Inc. has focused exclusively on Anatomic Pathology. NovoPath's mission is to provide unique and unparalleled solutions and services to all aspects of the Anatomic Pathology sector in a way that improves workflow, reduces the probability of human error, ensures results accuracy for greater patient safety, protects patient confidentiality, and above all, produces more precise and informative diagnostic outcomes. More information is available at http:\/\/www.NovoPath.com<\/a>. <\/p>\n About the Alzheimer's Association: <\/p>\n The Alzheimers AssociationTM is the only national health and social service organization dedicated to research, and to providing support and assistance to people with Alzheimers disease, their families and caregivers. Founded in 1980, the association works through a network of more than 80 chapters across the country. The Alzheimers Association Desert Southwest Chapter provides programs and services to tens of thousands of families including Helpline a 24\/7 assistance line, MedicAlert+Safe Return, Family Care Consultation, Support Groups, Education, Early Stage Programming and Legislative Advocacy. For additional information on Alzheimers disease or any of our programs, please call the Desert Southwest Chapter at 800.272.3900 or visit us online at http:\/\/www.alz.org\/dsw<\/a>. <\/p>\n ### <\/p>\n Susan Holland\/Public Relations Specialist NovoPath INC 336.693.9101 201 Email Information <\/p>\n<\/p>\n Continued here: Wally Soufi, CEO of NovoPath a leader in Anatomic Pathology Software Solutions, continues his companys multi-year commitment to the Alzheimer's Association and encourages CEOs across the country to join him in finding and supporting the causes about which they feel passionate. Princeton, NJ (PRWEB) March 09, 2012 In 2011, an estimated 5.4 million Americans of all ages had Alzheimers disease. For those 65 and over, this translates to one in eight people, and for individuals age 85 and over, nearly half had Alzheimers disease Continue reading
\nNovoPathTM Continues Support of Alzheimer\u2019s Association: Anatomic Pathology Leader Encourages Giving Back<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"